(Pakistan News & Features Services)
A signing ceremony of Pakistan-China biotechnology strategic cooperation was held at Beijing on September 22.
As the flagship medical corridor, Pakistani and Chinese companies will jointly build a cancer medical centre and laboratory.
Initially the 50-bed centre and laboratory with state of the art faculties is expected to be functional by early next year as construction of the building is in full swing in Islamabad.
The agreement was jointly signed by Dr Waqas Ahmed, CEO, Life Rehealth Technology Pakistan, and Beijing Anlong Gene Medicine Technology.
Under the framework, the Pakistani and Chinese companies will jointly carry out exploration and research on cancer medical treatment, and Chinese companies will also share their existing medical technologies with Pakistan.
Dr Waqas Ahmed , the CEO of Life Rehealth, who had been active in CPEC medical cooperation for a long time, observed in an exclusive interview that, the cancer rate in Pakistan was very high, especially lung cancer, liver cancer and so on.
“Therefore, the cooperation between Pakistan and China in this medical area was very necessary and will bring great benefits to Pakistanis. China and Pakistan are iron brothers and the Pakistani people deeply trust Chinese. So to develop biotechnology, the best partner must be our good brother China," he observed.
“The second reason is that China's rapid development in the medical field in recent years is well known to all, and the technology in oncology treatment has also been relatively mature. Therefore, we believe that through this cooperation, Pakistan can import advanced technology from China to help our patients,” Dr Waqas Ahmed, who graduated and settled in China, added.
Dr Wei Yujun, general manager of Anlong Gene, acknowledged that Pakistan was a friendly neighbour of China and, under the framework of BRI, they should strengthen medical cooperation with their iron brother.
No comments:
Post a Comment